Trial intelligence / Profile preview

Effect of ibuprofen and paracetamol on reactive oxygen species in leukocytes

2009-009036-77Phase 4Active

Sponsor
University of Oslo
Start
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of ibuprofen and acetaminophen, sponsored by University of Oslo. Primary endpoint: Leukocyte ROS activity. Started Feb 2009; status: active.

02

Drugs

ibuprofenacetaminophen

Beyond the preview

Go deeper on 2009-009036-77.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009036-77.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call